Á¦ 19 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãá°èÇмú´ëȸ : 2023-04-15
±³À°ÀÏÀÚ : 2023-04-15
±³À°Àå¼Ò : ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦
±³À°ÁÖÁ¦ : Á¦ 19 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãá°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ
´ã´çÀÚ : ´ëÇѳú¿°³ú¿°ÁõÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-2072-0629
À̸ÞÀÏ : encephalitis.office@kens.or.kr
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 09:00~09:30 ÇöÀåµî·Ï ()
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 09:30~09:45 A 31-year-old female with Refractory Primary CNS Vasculitis: What is the next possible alternative therapy? ÀåÀ±Çõ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 09:45~10:00 Neuronal Intranuclear Inclusion Disease in an Adult Patient: A Diagnostic Challenge ½Å¿ë¿ì(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:00~10:15 A 46-year old man with new-onset seizures È«»óºó(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:15~10:30 25-year-old woman with drug resistant epilepsy : A case of autoimmune epilepsy ÀÌÀ±°æ(µ¿¾Æ´ëº´¿ø)
ÈÞ½Ä 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:30~10:50 COFFEE BREAK ()
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 10:50~11:05 A case of LGI-1 antibody encephalitis with schizophrenia like symptom as an initial clinical manifestation ¼Û¿øºó(°¡Å縯°üµ¿´ë ±¹Á¦¼º¸ðº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 11:05~11:20 Scrub typhus ±è±ÙÅÂ(°è¸í´ëµ¿»êº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 11:20~11:35 A case of multiple cranial neuropathy after zoster ophthalmicus Ȳ¼ºÀº()
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 11:35~11:50 An 18-year-old male with seizure and anti-N-methyl-D-aspartate receptor antibody ±èÅÂÁØ(¾ÆÁִ뺴¿ø)
½Ä»ç 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 11:50~13:00 LUNCH ()
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 13:00~13:25 VTE treatment and Prophylaxis for Neurologic patient ³ª»óÈÆ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 13:25~13:50 Immunotherapy and infection risk ÀÌÇÑ»ó(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 13:50~14:15 Psychiatric symptom care in neurologic ward ±è¹Î¾Æ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 14:15~14:40 Breaking bad news and ethical decision À̼øÅÂ(¼¿ï´ëº´¿ø)
ÈÞ½Ä 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 14:40~15:00 COFFEE BREAK ()
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 15:00~15:25 Glymphatic evaluation using MRI ÃÖ½ÂÈ«(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 15:25~15:50 Macrophage activation syndrome ¹ÚÁø±Õ(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 15:50~16:15 Seizure management in encephalitis patients ÁÖ°Ç(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 04-15 ¼¿ï ¼¿ï´ëÇб³º´¿ø ÀÇ»ý¸í¿¬±¸¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ CMI 1Ãþ ¼¼ºÈ¯¿¬±¸È¦ 16:15~16:40 Recent Advances in Gene Therapy for Rare Diseases ¹®Àå¼·(¼¿ï´ëº´¿ø)